{"id":"https://openalex.org/W2013411037","doi":"https://doi.org/10.3109/00498254.2010.519061","title":"The metabolism and disposition of a potent inhibitor of hepatitis C virus NS3/4A protease","display_name":"The metabolism and disposition of a potent inhibitor of hepatitis C virus NS3/4A protease","publication_year":2010,"publication_date":"2010-10-07","ids":{"openalex":"https://openalex.org/W2013411037","doi":"https://doi.org/10.3109/00498254.2010.519061","mag":"2013411037","pmid":"https://pubmed.ncbi.nlm.nih.gov/20925584"},"language":"en","primary_location":{"id":"doi:10.3109/00498254.2010.519061","doi":"https://doi.org/10.3109/00498254.2010.519061","is_oa":false,"landing_page_url":"https://doi.org/10.3109/00498254.2010.519061","pdf_url":null,"source":{"id":"https://openalex.org/S48760969","display_name":"Xenobiotica","issn_l":"0049-8254","issn":["0049-8254","1366-5928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Xenobiotica","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036851868","display_name":"Edith S. Monteagudo","orcid":"https://orcid.org/0000-0003-2471-5695","observed_orcids":["https://orcid.org/0000-0003-2471-5695"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"E. Monteagudo","raw_affiliation_strings":["Department of DMPK, Istituto di Ricerche di Biologia Molecolare P. Angeletti, Merck Research Laboratories Rome, Via Pontina Km 30.600, Pomezia, Rome, Italy. e.monteagudo@irbm.it","Department of DMPK, Istituto di Ricerche di Biologia Molecolare (IRBM) P. Angeletti, Merck Research Laboratories Rome, Pomezia, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of DMPK, Istituto di Ricerche di Biologia Molecolare P. Angeletti, Merck Research Laboratories Rome, Via Pontina Km 30.600, Pomezia, Rome, Italy. e.monteagudo@irbm.it","institution_ids":[]},{"raw_affiliation_string":"Department of DMPK, Istituto di Ricerche di Biologia Molecolare (IRBM) P. Angeletti, Merck Research Laboratories Rome, Pomezia, Rome, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076006178","display_name":"Massimiliano Fonsi","orcid":"https://orcid.org/0000-0003-4549-1483","observed_orcids":["https://orcid.org/0000-0003-4549-1483"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Fonsi","raw_affiliation_strings":["Department of DMPK, Istituto di Ricerche di Biologia Molecolare (IRBM) P. Angeletti, Merck Research Laboratories Rome, Pomezia, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of DMPK, Istituto di Ricerche di Biologia Molecolare (IRBM) P. Angeletti, Merck Research Laboratories Rome, Pomezia, Rome, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082048814","display_name":"Xiaoyan Chu","orcid":"https://orcid.org/0000-0001-7223-9000","observed_orcids":["https://orcid.org/0000-0001-7223-9000"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"X. Chu","raw_affiliation_strings":["Department of DMPK, Merck Research Laboratories, Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of DMPK, Merck Research Laboratories, Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027914044","display_name":"Kelly Bleasby","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Bleasby","raw_affiliation_strings":["Department of DMPK, Merck Research Laboratories, Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of DMPK, Merck Research Laboratories, Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064222916","display_name":"Raymond Evers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Evers","raw_affiliation_strings":["Department of DMPK, Merck Research Laboratories, Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of DMPK, Merck Research Laboratories, Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033679363","display_name":"Vincenzo Pucci","orcid":"https://orcid.org/0000-0002-1222-8366","observed_orcids":["https://orcid.org/0000-0002-1222-8366"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. Pucci","raw_affiliation_strings":["Department of DMPK, Istituto di Ricerche di Biologia Molecolare (IRBM) P. Angeletti, Merck Research Laboratories Rome, Pomezia, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of DMPK, Istituto di Ricerche di Biologia Molecolare (IRBM) P. Angeletti, Merck Research Laboratories Rome, Pomezia, Rome, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054699653","display_name":"Maria Vittoria Orsale","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M.V. Orsale","raw_affiliation_strings":["Department of DMPK, Istituto di Ricerche di Biologia Molecolare (IRBM) P. Angeletti, Merck Research Laboratories Rome, Pomezia, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of DMPK, Istituto di Ricerche di Biologia Molecolare (IRBM) P. Angeletti, Merck Research Laboratories Rome, Pomezia, Rome, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075397807","display_name":"Simona Cianetti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Cianetti","raw_affiliation_strings":["Department of DMPK, Istituto di Ricerche di Biologia Molecolare (IRBM) P. Angeletti, Merck Research Laboratories Rome, Pomezia, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of DMPK, Istituto di Ricerche di Biologia Molecolare (IRBM) P. Angeletti, Merck Research Laboratories Rome, Pomezia, Rome, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047090164","display_name":"Marco Ferrara","orcid":"https://orcid.org/0000-0002-7718-0308","observed_orcids":["https://orcid.org/0000-0002-7718-0308"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Ferrara","raw_affiliation_strings":["Department of Medicinal Chemistry, Istituto di Ricerche di Biologia Molecolare (IRBM) P. Angeletti, Merck Research Laboratories Rome, Pomezia, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Istituto di Ricerche di Biologia Molecolare (IRBM) P. Angeletti, Merck Research Laboratories Rome, Pomezia, Rome, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"S. Harper","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Harper","raw_affiliation_strings":["Department of Medicinal Chemistry, Istituto di Ricerche di Biologia Molecolare (IRBM) P. Angeletti, Merck Research Laboratories Rome, Pomezia, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Istituto di Ricerche di Biologia Molecolare (IRBM) P. Angeletti, Merck Research Laboratories Rome, Pomezia, Rome, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111520231","display_name":"R. Laufer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Laufer","raw_affiliation_strings":["Department of Pharmacology, Istituto di Ricerche di Biologia Molecolare (IRBM) P. Angeletti, Merck Research Laboratories Rome, Pomezia, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Istituto di Ricerche di Biologia Molecolare (IRBM) P. Angeletti, Merck Research Laboratories Rome, Pomezia, Rome, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060422552","display_name":"Michael Rowley","orcid":"https://orcid.org/0000-0003-2672-1255","observed_orcids":["https://orcid.org/0000-0003-2672-1255"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Rowley","raw_affiliation_strings":["Department of Medicinal Chemistry, Istituto di Ricerche di Biologia Molecolare (IRBM) P. Angeletti, Merck Research Laboratories Rome, Pomezia, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Istituto di Ricerche di Biologia Molecolare (IRBM) P. Angeletti, Merck Research Laboratories Rome, Pomezia, Rome, Italy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044099332","display_name":"Vincenzo Summa","orcid":"https://orcid.org/0000-0002-6288-2681","observed_orcids":["https://orcid.org/0000-0002-6288-2681"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. Summa","raw_affiliation_strings":["Department of Medicinal Chemistry, Istituto di Ricerche di Biologia Molecolare (IRBM) P. Angeletti, Merck Research Laboratories Rome, Pomezia, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Istituto di Ricerche di Biologia Molecolare (IRBM) P. Angeletti, Merck Research Laboratories Rome, Pomezia, Rome, Italy","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5036851868"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.1161,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.79050175,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"40","issue":"12","first_page":"826","last_page":"839"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.88919997215271,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.88919997215271,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.08940000087022781,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.014999999664723873,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/compound-a","display_name":"compound A","score":0.9120000004768372},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.8420000076293945},{"id":"https://openalex.org/keywords/drug-disposition","display_name":"drug disposition","score":0.7689999938011169},{"id":"https://openalex.org/keywords/hepatic-uptake-transporters","display_name":"hepatic uptake transporters","score":0.7879999876022339},{"id":"https://openalex.org/keywords/oatp1b1","display_name":"OATP1B1","score":0.9819999933242798},{"id":"https://openalex.org/keywords/oatp1b3","display_name":"OATP1B3","score":0.9929999709129333},{"id":"https://openalex.org/keywords/oatp1b2","display_name":"Oatp1b2","score":0.9089999794960022},{"id":"https://openalex.org/keywords/glutathione-conjugation","display_name":"glutathione conjugation","score":0.9399999976158142},{"id":"https://openalex.org/keywords/hepatic-first-pass-metabolism","display_name":"hepatic first-pass metabolism","score":0.7580000162124634},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.9079999923706055},{"id":"https://openalex.org/keywords/biliary-excretion","display_name":"biliary excretion","score":0.5820000171661377},{"id":"https://openalex.org/keywords/hepatocyte-uptake","display_name":"hepatocyte uptake","score":0.7829999923706055},{"id":"https://openalex.org/keywords/drug-candidates","display_name":"drug candidates","score":0.33500000834465027}],"concepts":[{"id":"https://openalex.org/C132379496","wikidata":"https://www.wikidata.org/wiki/Q83141645","display_name":"NS3","level":4,"score":0.654274582862854},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6258090734481812},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.5988078713417053},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5560768246650696},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.5105803608894348},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4807000756263733},{"id":"https://openalex.org/C2781143361","wikidata":"https://www.wikidata.org/wiki/Q55761529","display_name":"Protease inhibitor (pharmacology)","level":5,"score":0.4596445560455322},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.45605891942977905},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.43518713116645813},{"id":"https://openalex.org/C87644729","wikidata":"https://www.wikidata.org/wiki/Q547502","display_name":"Microsome","level":3,"score":0.4242948293685913},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3011183440685272},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.284277081489563},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.20481985807418823},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.17920517921447754},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.17339780926704407},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.07601076364517212},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000085242","descriptor_name":"Viral Proteases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001692","descriptor_name":"Biological Transport","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D012697","descriptor_name":"Serine Endopeptidases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017361","descriptor_name":"Viral Nonstructural Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D017361","descriptor_name":"Viral Nonstructural Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D026901","descriptor_name":"Membrane Transport Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D043583","descriptor_name":"Nucleoside-Triphosphatase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053487","descriptor_name":"DEAD-box RNA Helicases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053719","descriptor_name":"Tandem Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053858","descriptor_name":"Metabolic Networks and Pathways","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.3109/00498254.2010.519061","doi":"https://doi.org/10.3109/00498254.2010.519061","is_oa":false,"landing_page_url":"https://doi.org/10.3109/00498254.2010.519061","pdf_url":null,"source":{"id":"https://openalex.org/S48760969","display_name":"Xenobiotica","issn_l":"0049-8254","issn":["0049-8254","1366-5928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Xenobiotica","raw_type":"journal-article"},{"id":"pmid:20925584","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20925584","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Xenobiotica; the fate of foreign compounds in biological systems","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W1965813400","https://openalex.org/W1966043736","https://openalex.org/W1986308869","https://openalex.org/W1995778111","https://openalex.org/W2001138984","https://openalex.org/W2022057836","https://openalex.org/W2027545702","https://openalex.org/W2029323175","https://openalex.org/W2036520108","https://openalex.org/W2047208492","https://openalex.org/W2062395204","https://openalex.org/W2072029488","https://openalex.org/W2077103006","https://openalex.org/W2084553493","https://openalex.org/W2085587542","https://openalex.org/W2091026598","https://openalex.org/W2092910855","https://openalex.org/W2097729035","https://openalex.org/W2106791445","https://openalex.org/W2107713887","https://openalex.org/W2108836992","https://openalex.org/W2112876622","https://openalex.org/W2115151001","https://openalex.org/W2127685726","https://openalex.org/W2140231399","https://openalex.org/W2140369033","https://openalex.org/W2142234431","https://openalex.org/W2142684817","https://openalex.org/W2148917087","https://openalex.org/W2154155208","https://openalex.org/W2317554121","https://openalex.org/W3126246200"],"related_works":["https://openalex.org/W2159808261","https://openalex.org/W2003156305","https://openalex.org/W2062282550","https://openalex.org/W2725446377","https://openalex.org/W2902212975","https://openalex.org/W3110060352","https://openalex.org/W7100034232","https://openalex.org/W2140231399","https://openalex.org/W1995778111","https://openalex.org/W2143278579"],"abstract_inverted_index":{"Compound":[0,51,86,164,213],"A":[1,52,87,165,214],"((1aR,5S,8S,10R,22aR)-5-tert-butyl-N-{(1R,2S)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[12,11-b]quinoline-8-carboxamide)":[2],"is":[3,60,126],"a":[4,7,44,102,146,198,223],"prototype":[5],"of":[6,9,12,47,163,171,201,212,229],"series":[8],"subnanomolar":[10],"inhibitors":[11,27],"genotypes":[13],"1,":[14],"2,":[15],"and":[16,39,76,90,95,98,110,117,144,173,209],"3":[17],"hepatitis":[18,230],"C":[19],"virus":[20],"(HCV)":[21],"NS3/4A":[22,25],"proteases.":[23],"HCV":[24,37,49],"protease":[26],"have":[28],"demonstrated":[29,88],"high":[30,199],"antiviral":[31],"effects":[32],"in":[33,57,74,84,168],"patients":[34],"with":[35,136],"chronic":[36],"infection":[38],"are":[40,215],"likely":[41,127],"to":[42,65,100,128,131,184,196,204,218],"form":[43],"key":[45],"component":[46],"future":[48],"therapy.":[50],"showed":[53,77],"excellent":[54],"liver":[55,120,169],"exposure":[56,83],"rats,":[58],"which":[59],"essential":[61],"for":[62,104,111,123,226],"compounds":[63],"intended":[64],"treat":[66],"HCV.":[67],"The":[68,119,175,207],"compound":[69,125,203],"was":[70,141,181,194],"mainly":[71,142],"eliminated":[72],"intact":[73],"bile":[75],"greater":[78],"than":[79],"dose":[80],"proportional":[81],"systemic":[82],"rats.":[85],"time-":[89],"temperature-dependent":[91],"uptake":[92,107,114,134],"into":[93],"rat":[94,105],"human":[96,112],"hepatocytes":[97],"proved":[99],"be":[101,129,156],"substrate":[103],"hepatic":[106,113,133,186],"transporter":[108],"Oatp1b2":[109],"transporters":[115],"OATP1B1":[116],"OATP1B3.":[118],"selectivity":[121],"observed":[122],"this":[124],"due":[130,183],"transporter-mediated":[132],"together":[135],"moderate":[137],"passive":[138],"permeability.":[139],"Metabolism":[140],"CYP3A-mediated":[143],"generated":[145],"reactive":[147],"epoxide":[148],"on":[149],"the":[150,191,202,205,227],"vinylcyclopropyl":[151],"sulfonamide":[152],"moiety":[153],"that":[154],"could":[155],"quenched":[157],"by":[158],"glutathione.":[159],"Similar":[160],"metabolic":[161],"profiles":[162],"were":[166],"obtained":[167],"microsomes":[170],"rats":[172],"humans.":[174],"oral":[176],"bioavailability":[177],"at":[178],"5":[179],"mg/kg":[180],"low":[182],"extensive":[185],"first-pass":[187],"effect":[188],"but":[189],"clearly":[190],"intestinal":[192],"absorption":[193],"enough":[195],"deliver":[197],"amount":[200],"liver.":[206],"metabolism":[208],"disposition":[210],"properties":[211],"particularly":[216],"attractive":[217],"support":[219],"its":[220],"evaluation":[221],"as":[222],"drug":[224],"candidate":[225],"treatment":[228],"C.":[231]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}